Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Nasrallah

Showing results (101-110 of 124) with videos related to

Pageof 13
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 2, 2023
ROS1 Alterations as a Potential Driver of Gliomas in Infant, Pediatric, and Adult PatientsDavid M Meredith, Linda D Cooley, Adrian Dubuc, et al.
Journal of Medical Imaging (Bellingham, Wash.)|September 2, 2024
Predicting peritumoral glioblastoma infiltration and subsequent recurrence using deep-learning-based analysis of multi-parametric magnetic resonance imagingSunwoo Kwak, Hamed Akbari, Jose A Garcia, et al.
Nature|September 4, 2024
A pathology foundation model for cancer diagnosis and prognosis predictionXiyue Wang, Junhan Zhao, Eliana Marostica, et al.
Cancer Cell|July 11, 2018
Epidermal Growth Factor Receptor Extracellular Domain Mutations in Glioblastoma Present Opportunities for Clinical Imaging and Therapeutic DevelopmentZev A Binder, Amy Haseley Thorne, Spyridon Bakas, et al.
Nature Communications|September 29, 2025
Uncertainty-aware ensemble of foundation models differentiates glioblastoma from its mimicsJunhan Zhao, Shih-Yen Lin, Raphaël Attias, et al.
Nature Communications|May 13, 2026
Personalized machine learning-guided radiation dose escalation in newly diagnosed glioblastoma: prospective pilot studyHamed Akbari, Suyash Mohan, Fang Liu, et al.
Neuroradiology|July 19, 2023
Association of partial T2-FLAIR mismatch sign and isocitrate dehydrogenase mutation in WHO grade 4 gliomas: results from the ReSPOND consortiumMatthew D Lee, Sohil H Patel, Suyash Mohan, et al.
Acta Neuropathologica|April 9, 2025
Diffuse astrocytoma, AYA-type, frequently MAPK-altered: report of 45 patientsOmkar Singh, Christopher Dampier, Zied Abdullaev, et al.
Cell Reports. Medicine|December 17, 2025
Contrastive learning enhances fairness in pathology artificial intelligence systemsShih-Yen Lin, Pei-Chen Tsai, Fang-Yi Su, et al.
Scientific Data|July 29, 2022
The University of Pennsylvania glioblastoma (UPenn-GBM) cohort: advanced MRI, clinical, genomics, & radiomicsSpyridon Bakas, Chiharu Sako, Hamed Akbari, et al.
Pageof 13

Showing results (101-110 of 124) with videos related to

Sort By:
Pageof 13
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 2, 2023
ROS1 Alterations as a Potential Driver of Gliomas in Infant, Pediatric, and Adult PatientsDavid M Meredith, Linda D Cooley, Adrian Dubuc, et al.
Journal of Medical Imaging (Bellingham, Wash.)|September 2, 2024
Predicting peritumoral glioblastoma infiltration and subsequent recurrence using deep-learning-based analysis of multi-parametric magnetic resonance imagingSunwoo Kwak, Hamed Akbari, Jose A Garcia, et al.
Nature|September 4, 2024
A pathology foundation model for cancer diagnosis and prognosis predictionXiyue Wang, Junhan Zhao, Eliana Marostica, et al.
Cancer Cell|July 11, 2018
Epidermal Growth Factor Receptor Extracellular Domain Mutations in Glioblastoma Present Opportunities for Clinical Imaging and Therapeutic DevelopmentZev A Binder, Amy Haseley Thorne, Spyridon Bakas, et al.
Nature Communications|September 29, 2025
Uncertainty-aware ensemble of foundation models differentiates glioblastoma from its mimicsJunhan Zhao, Shih-Yen Lin, Raphaël Attias, et al.
Nature Communications|May 13, 2026
Personalized machine learning-guided radiation dose escalation in newly diagnosed glioblastoma: prospective pilot studyHamed Akbari, Suyash Mohan, Fang Liu, et al.
Neuroradiology|July 19, 2023
Association of partial T2-FLAIR mismatch sign and isocitrate dehydrogenase mutation in WHO grade 4 gliomas: results from the ReSPOND consortiumMatthew D Lee, Sohil H Patel, Suyash Mohan, et al.
Acta Neuropathologica|April 9, 2025
Diffuse astrocytoma, AYA-type, frequently MAPK-altered: report of 45 patientsOmkar Singh, Christopher Dampier, Zied Abdullaev, et al.
Cell Reports. Medicine|December 17, 2025
Contrastive learning enhances fairness in pathology artificial intelligence systemsShih-Yen Lin, Pei-Chen Tsai, Fang-Yi Su, et al.
Scientific Data|July 29, 2022
The University of Pennsylvania glioblastoma (UPenn-GBM) cohort: advanced MRI, clinical, genomics, & radiomicsSpyridon Bakas, Chiharu Sako, Hamed Akbari, et al.
Pageof 13